Citations (1)
Keep up to date with the latest research on this topic with citation updates for this article.
Clinical Epidemiology
Volume 15, 2023 - Issue
REVIEW
Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map
Carolina Requeijo1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, SpainCorrespondence[email protected]
https://orcid.org/0000-0003-3479-4550View further author information
https://orcid.org/0000-0003-3479-4550View further author information, Javier Bracchiglione1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain;2 Interdisciplinary Centre for Health Studies (CIESAL), Valparaiso University, Viña del Mar, Chile;3 CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spainhttps://orcid.org/0000-0001-8738-2184View further author information
https://orcid.org/0000-0001-8738-2184View further author information, Nicolás Meza2 Interdisciplinary Centre for Health Studies (CIESAL), Valparaiso University, Viña del Mar, Chilehttps://orcid.org/0000-0001-9505-0358View further author information
https://orcid.org/0000-0001-9505-0358View further author information, , Josefina Salazar1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spainhttps://orcid.org/0000-0002-6448-5946View further author information
https://orcid.org/0000-0002-6448-5946View further author information, Marilina Santero1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spainhttps://orcid.org/0000-0001-5371-0979View further author information
https://orcid.org/0000-0001-5371-0979View further author information, Adriana-G Meade1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spainhttps://orcid.org/0000-0002-7572-3524View further author information
https://orcid.org/0000-0002-7572-3524View further author information, María Jesús Quintana1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain;3 CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain;4 Autonomous University of Barcelona, Barcelona, Spainhttps://orcid.org/0000-0002-1055-9786View further author information
https://orcid.org/0000-0002-1055-9786View further author information, , Anna Selva3 CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain;5 Clinical Epidemiology and Cancer Screening, Parc Taulí Hospital Universitari, Parc Taulí Research and Innovation Institute Foundation (I3PT-CERCA), Autonomous University of Barcelona, Sabadell, Spainhttps://orcid.org/0000-0002-2754-3158View further author information
https://orcid.org/0000-0002-2754-3158View further author information, Ivan Solà1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain;3 CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spainhttps://orcid.org/0000-0003-0078-3706View further author information
https://orcid.org/0000-0003-0078-3706View further author information, Gerard Urrútia1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain;3 CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spainhttps://orcid.org/0000-0002-8850-0960View further author information
https://orcid.org/0000-0002-8850-0960View further author information & Xavier Bonfill Cosp1 Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain;3 CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain;4 Autonomous University of Barcelona, Barcelona, Spainhttps://orcid.org/0000-0003-1530-3509View further author information
https://orcid.org/0000-0003-1530-3509View further author information show all